These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17889127

  • 1. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R, Pastor MC, Bayes B, Malumbres S, Homs M, Llopis MA, Bonet J, Romero R.
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [Abstract] [Full Text] [Related]

  • 2. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
    White M, Ross H, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies R, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J.
    Transplantation; 2006 Sep 27; 82(6):763-70. PubMed ID: 17006323
    [Abstract] [Full Text] [Related]

  • 3. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B.
    Transplant Proc; 2008 Oct 27; 40(1):151-5. PubMed ID: 18261573
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
    Transplant Proc; 2006 Oct 27; 38(1):81-5. PubMed ID: 16504670
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
    Transpl Int; 2006 Aug 27; 19(8):657-66. PubMed ID: 16827683
    [Abstract] [Full Text] [Related]

  • 12. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 13. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
    Sadeghi M, Daniel V, Naujokat C, Wiesel M, Hergesell O, Opelz G.
    Transpl Int; 2005 Feb 27; 18(2):177-85. PubMed ID: 15691270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R, Shah G, Adler W, Kittur D.
    Clin Transplant; 2004 Feb 27; 18 Suppl 12():67-71. PubMed ID: 15217411
    [Abstract] [Full Text] [Related]

  • 17. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E, Delgado P, Alvarez A, Cobo M, Pérez L, González-Posada JM, Hortal L, Gallego R, García JJ, Checa M, Morales A, Salido E, Hernández D, Torres A.
    Nephrol Dial Transplant; 2008 Apr 27; 23(4):1436-41. PubMed ID: 18029372
    [Abstract] [Full Text] [Related]

  • 18. Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes.
    Walker RG, Cottrell S, Sharp K, Tripodi R, Nicholls KM, Fraser I, Varigos GA, Butcher BE.
    Nephrology (Carlton); 2007 Dec 27; 12(6):607-14. PubMed ID: 17995589
    [Abstract] [Full Text] [Related]

  • 19. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J.
    Transplant Proc; 2007 Sep 27; 39(7):2167-9. PubMed ID: 17889126
    [Abstract] [Full Text] [Related]

  • 20. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV, Nash MM, McFarlane PA, Zaltzman JS.
    Nephron Clin Pract; 2004 Sep 27; 97(2):c35-40. PubMed ID: 15218328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.